1. Home
  2. PDT vs IRWD Comparison

PDT vs IRWD Comparison

Compare PDT & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Premium Dividend Fund

PDT

John Hancock Premium Dividend Fund

HOLD

Current Price

$12.84

Market Cap

624.7M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$5.24

Market Cap

520.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDT
IRWD
Founded
1989
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
624.7M
520.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
PDT
IRWD
Price
$12.84
$5.24
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$5.74
AVG Volume (30 Days)
145.6K
7.4M
Earning Date
01-01-0001
02-26-2026
Dividend Yield
8.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.18
Revenue
N/A
$338,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$37.22
P/E Ratio
N/A
$30.44
Revenue Growth
N/A
N/A
52 Week Low
$8.77
$0.53
52 Week High
$13.05
$5.78

Technical Indicators

Market Signals
Indicator
PDT
IRWD
Relative Strength Index (RSI) 53.68 71.76
Support Level $12.74 $4.17
Resistance Level $12.97 $5.57
Average True Range (ATR) 0.12 0.39
MACD 0.02 0.09
Stochastic Oscillator 64.86 80.53

Price Performance

Historical Comparison
PDT
IRWD

About PDT John Hancock Premium Dividend Fund

John Hancock Premium Div Fund is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest capital growth. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, capital preferred securities, and short-term investments.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: